Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of parana, Curitiba, Brazil.
SEMPR, Serviço de Endocrinologia e Metabologia do Hospital de Clínicas da Universidade Federal do Paraná, Avenida Agostinho Leão Junior, 285, 80030-110, Curitiba, PR, Brazil.
Rev Endocr Metab Disord. 2024 Jun;25(3):453-455. doi: 10.1007/s11154-024-09889-7. Epub 2024 May 27.
Hypopituitarism is a rare endocrine disorder characterized by insufficient hormone secretion from the pituitary gland. This condition leads to deficient production of one or more pituitary hormones, including growth hormone (GH), thyroid-stimulating hormone (TSH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), adrenocorticotropic hormone (ACTH), and antidiuretic hormone (ADH), also called arginine vasopressin (AVP). Symptoms vary widely and are often not, late recognized.Diagnosis typically involves a thorough clinical evaluation, hormone level assessments, and neuroimaging studies to identify underlying causes. Treatment aims to replace deficient hormones and address the underlying cause and related complications when possible. In this special issue we address diagnosis, comorbidities, and management of hypopituitarism. We hope that it will help healthcare professionals to manage their patients.
垂体功能减退症是一种罕见的内分泌疾病，其特征是垂体激素分泌不足。这种情况会导致一种或多种垂体激素的产生不足，包括生长激素（GH）、促甲状腺激素（TSH）、促黄体生成素（LH）、促卵泡激素（FSH）、促肾上腺皮质激素（ACTH）和抗利尿激素（ADH），也称为精氨酸血管加压素（AVP）。症状差异很大，且常常未被及时识别。诊断通常包括全面的临床评估、激素水平评估和神经影像学研究，以确定潜在病因。治疗旨在补充缺乏的激素，并尽可能针对潜在病因和相关并发症进行治疗。在本期特刊中，我们探讨了垂体功能减退症的诊断、合并症和管理。我们希望它能帮助医疗保健专业人员管理他们的患者。
